Navigation Links
Success of Vaccines Won’t Limit IVD Market: Kalorama Report
Date:12/18/2013

New York, NY (PRWEB) December 18, 2013

Vaccines have been successful in preventing disease, but according to Kalorama Information that doesn’t mean they will hurt the market for products to test for those diseases. The healthcare market research publisher says a variety of factors will boost the infectious disease IVD market, even if vaccines are developed and widely distributed. The world market for infectious disease tests is estimated at $14.5 billion in 2012 and with 5% CAGR will reach $18.3 billion in 2017, according to their latest report “The World Market for Infectious Disease Diagnostic Tests.”

“One would expect that the eventual impact of a successful vaccine strategy would be the complete eradication of the disease and therefore little or no use for a diagnostic test for that particular disease,” said Shara Rosen, Kalorama analyst and the author of the report. “However, in light of the recent re-emergence of tuberculosis, measles and malaria; and the persistence of polio, it is unrealistic to think that a disease could be totally eliminated around the world at the same time.”

The report notes that pathogens constantly change their genetic make-up, which challenges the development of vaccines against infectious diseases. This genetic flexibility allows many infectious agents to mutate or evolve into more deadly strains against which humans have little or no resistance: the HIV and influenza viruses, for example, constantly mutate and recombine to find their way through the host defense mechanisms.

Further, the report notes that the vaccine market may not be strong enough to encourage enough entrants for all the possible infectious diseases. Even existing vaccine markets sometimes fail.

After the flu epidemic scare of 2009 resulted in a shortage of flu vaccines, the industry prepared to avoid this in the future. But things did not quite work out for them. In 2012, companies produced about 145 million doses and only about 129 million were distributed. In 2011, companies lost even more on the flu vaccine because it was such a light flu season and fewer people decided to get the shot.

“These diseases can be unpredictable and so companies have cautiously entered the market,” Rosen said.

For these reasons, Kalorama’s report says the traditional testing and treatment model will play a long-term role in combating the scourge of infectious disease.

The report, “The World Market for Infectious Disease Diagnostic Tests,” has more information on the impact of vaccines on testing, and other trends. The report also has complete market estimates and forecasts. The report can be found at: http://www.kaloramainformation.com/Infectious-Disease-Diagnostic-7841652/.

About Kalorama Information

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11429182.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Psychological testing may predict success in soccer
2. Report outlines successes, challenges in cancer prevention efforts
3. Small neural focus groups predict anti-smoking ad success
4. T-Shirt, Gift Card Giveaways Raise Blood Drives Success
5. First, Second Kidney Transplants Have Similar Success: Study
6. CNIO scientists successfully test the first gene therapy against aging-associated decline
7. Ben-Gurion U. researchers successfully test solar desalination system for arid land agriculture
8. Dana-Farber: Study reports first success of targeted therapy in type of non-small cell lung cancer
9. Alzheimers vaccine trial a success
10. The first day of development -- a window to successful pregnancy
11. Moffitt researcher, colleagues find success with new immune approach to fighting some cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
Breaking Medicine Technology: